Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

Share Price Information for Treatt (TET)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 513.00
Bid: 512.00
Ask: 516.00
Change: 2.00 (0.39%)
Spread: 4.00 (0.781%)
Open: 507.00
High: 515.00
Low: 505.00
Prev. Close: 511.00
TET Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

5 Apr 2019 07:00

RNS Number : 2073V
Treatt PLC
05 April 2019
 

 

 

5 April 2019

 

TREATT PLC

("Treatt" or "the Group")

 

Trading Update for the half year ended 31 March 2019

 

Treatt, the manufacturer and supplier of innovative ingredient solutions for the flavour, fragrance, beverage and consumer product industries today publishes a trading update for the half year ended 31 March 2019 (the "Period").

 

The Board is pleased to confirm that following six consecutive years of growth, the business has continued to perform well in the current financial year with revenue for the Period up by approximately 7% compared with the same period in the prior year (5% in constant currency). The growth in the Period was particularly pleasing against a market backdrop of price weakness in some key raw materials for our largest product category, citrus, which we expect to continue into the second half of the current financial year.

 

Whilst citrus continues to dominate our category mix, the fruit and vegetables, tea and sugar reduction categories are also driving revenues, representing 69% of the year-on-year growth for the Period. The vast majority of Treatt's portfolio is targeted at the growing demand from consumers for more natural and clean-label products which is feeding both into our results for the Period as well as our encouraging opportunity pipeline.

 

A key element of the Group's current five-year strategy through to 2022 is to invest in the Group's capacity and scientific capabilities in order to deliver long term growth and value for shareholders. We are, therefore, pleased to confirm that the $14m expansion of our US facility was completed in March 2019 and will become fully operational in June this year. This project has been managed whilst continuing to deliver the excellent product quality and service our global client base has come to expect, without disruption. In the UK, construction of our £35m relocation project is expected to commence this summer, and occupancy to begin in summer 2020.

 

Whilst the Group has in place a hedging strategy to try to ensure that the impact of exchange rate movements is broadly neutral to the income statement over the course of a financial year, as has been experienced previously, there can be material effects over shorter periods of time. During the Period there was a weakening in the USD/GBP exchange rate and, as a result, the Board anticipates a net negative FX impact on the results for the Period of approximately £0.6m.

 

Outlook

We are encouraged by our order book which is comfortably up compared with the same time in the prior year, notwithstanding the weakness in some key citrus raw material input prices. This reflects the success of our continued strategic focus on key product categories and geographical markets and the Board, therefore, continues to believe that profit before tax and exceptional items will be in line with its expectations for the financial year ending 30 September 2019.

 

The Board expects to announce Treatt's half year results for the six months ended 31 March 2019 on 7 May 2019.

 

 

 

 

Enquiries:

 

Treatt plc +44 (0)1284 702500

Daemmon Reeve Chief Executive Officer

Richard Hope Chief Financial Officer

 

Broker

Investec Investment Banking

Patrick Robb +44 (0)20 7597 5970

David Anderson

Alex Wright

 

Public relations

DRD Partnership

Lawrence Dore +44 (0)20 3951 0349

 

About the Group

Treatt is a global, independent supplier of innovative ingredient solutions for the flavour, fragrance and multinational consumer product industries, particularly in the beverage sector. Renowned for its technical expertise and knowledge of ingredients, their origins and market conditions, Treatt is recognised as a leader in its field.

 

The Group employs over 300 staff in Europe, North America, Africa and Asia and has manufacturing facilities in the UK, USA and Kenya. Its international foot print enables the Group to deliver powerful and integrated solutions for the food, beverage and fragrance industries across the globe.

 

 

For further information about the Group, visit www.treatt.com.

 

 

 

CAUTIONARY STATEMENT ABOUT FORWARD-LOOKING STATEMENTS

This announcement contains forward-looking statements that are subject to risk factors associated with, among other things, the economic and business circumstances occurring from time to time in the countries, sectors and markets in which the Group operates. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a wide range of variables which could cause actual results to differ materially from those currently anticipated. No assurances can be given that the forward-looking statements in this announcement will be realised. The forward-looking statements reflect the knowledge and information available at the date of preparation of this announcement and the Group undertakes no obligation to update these forward-looking statements. Nothing in this announcement should be construed as a profit forecast.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTBLGDSRBGBGCS
Date   Source Headline
26th Jan 20184:32 pmRNSResult of AGM
25th Jan 20181:47 pmRNSHolding(s) in Company
29th Dec 20177:00 amRNSVoting Rights and Captial
22nd Dec 20179:01 amRNSHolding(s) in Company
21st Dec 20173:23 pmRNSHolding(s) in Company
19th Dec 20173:46 pmRNSDirector/PDMR Shareholding
19th Dec 20173:20 pmRNSHolding(s) in Company
18th Dec 20173:41 pmRNSResult of General Meeting
14th Dec 201710:41 amRNSAnnual Financial Report
6th Dec 20175:04 pmRNSHolding(s) in Company
1st Dec 20174:16 pmRNSBlock Listing Six Monthly Return
1st Dec 20177:00 amRNSTotal Voting Rights
28th Nov 20177:00 amRNSPlacing to raise £21.6 million
28th Nov 20177:00 amRNSFinal Results
10th Nov 201712:34 pmRNSHolding(s) in Company
2nd Oct 20177:00 amRNSTrading Update
29th Sep 20175:14 pmRNSTotal Voting Rights
26th Sep 20178:54 amRNSHolding(s) in Company
21st Sep 201712:23 pmRNSHolding(s) in Company
21st Aug 201711:09 amRNSDirector/PDMR Shareholding
2nd Aug 20175:07 pmRNSTotal Voting Rights
20th Jul 20171:50 pmRNSDirector/PDMR Shareholding
5th Jun 20171:35 pmRNSBlock Listing Six Monthly Return
23rd May 20179:30 amRNSBlock Listing Application
11th May 20174:05 pmRNSHolding(s) in Company
11th May 20174:01 pmRNSDirector/PDMR Shareholding
10th May 20172:53 pmRNSHolding(s) in Company
9th May 20177:00 amRNSHalf-year Report
5th Apr 20174:41 pmRNSHolding(s) in Company
3rd Apr 20175:25 pmRNSDirector/PDMR Shareholding
31st Mar 20173:57 pmRNSTotal Voting Rights
30th Mar 20177:00 amRNSTrading Statement
27th Mar 20179:30 amRNSHolding(s) in Company
24th Mar 20173:44 pmRNSDirector/PDMR Shareholding
2nd Mar 20174:50 pmRNSHolding(s) in Company
23rd Feb 20177:00 amRNSDirector/PDMR Shareholding
23rd Feb 20177:00 amRNSTrading Statement
20th Feb 20174:03 pmRNSDirector/PDMR Shareholding
14th Feb 20178:15 amRNSHolding(s) in Company
10th Feb 20179:41 amRNSHolding(s) in Company
1st Feb 20172:19 pmRNSDirector/PDMR Shareholding
30th Jan 20175:58 pmRNSNotification of a Transaction of a Director
27th Jan 20174:42 pmRNSResult of AGM
27th Jan 20177:15 amRNSTrading Statement
30th Dec 20167:00 amRNSTotal Voting Rights
30th Dec 20167:00 amRNSAnnual Information Update
22nd Dec 20163:11 pmRNSUpdate on Site Relocation
20th Dec 201610:26 amRNSDirector/PDMR Shareholding
13th Dec 20161:11 pmRNSNotification of Transactions of Directors
9th Dec 20163:05 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.